BioSpace News Archive

Business

Vertex Raises Cystic Fibrosis Sales Forecast Amid Strong Trikafta Demand

The biopharma company reported sales of $2.24 billion in the second quarter for the cystic fibrosis treatment, beating analysts’ estimate, after it won FDA approval in children ages two to five in April.

August 2, 2023
·
2 min read
·
Nick Paul Taylor
Policy

Cancer Drug Manufacturer Intas Slapped with FDA Warning Letter

Following reports of destroyed and discarded data, the U.S. regulator issued a warning letter to India’s Intas Pharmaceuticals regarding violations of current good manufacturing practice.

August 2, 2023
·
2 min read
·
Tristan Manalac
Policy

GSK Sues Pfizer for Alleged RSV Vaccine Patent Infringement

The lawsuit alleges that Pfizer infringed GSK’s patents on respiratory syncytial virus shots. The complaint comes just months after both companies had their respective RSV vaccines approved.

August 2, 2023
·
1 min read
·
David Adam
Business

Illumina, Guardant Dismiss Litigation and Extend Commercial Relationship

Following a year-long legal battle, Illumina is dropping the intellectual property allegations against Guardant. The companies have also entered into a new long-term purchase and supply commitment.

August 2, 2023
·
2 min read
·
Kate Goodwin
Drug Development

GLP-1 Drugs Show Promise in Alcohol, Opioid Use Disorders

Early research and anecdotal evidence indicate that the popular diabetes and obesity drugs could treat some patients with addictive disorders.

August 2, 2023
·
5 min read
·
Heather McKenzie
Business

AmerisourceBergen Reports Fiscal 2023 Third Quarter Results

AmerisourceBergen Corporation reported that in its fiscal year 2023 third quarter ended June 30, 2023, revenue increased 11.5 percent year-over-year to $66.9 billion.

August 2, 2023
·
49 min read
Business

OMass Therapeutics Expands Leadership Team with Two New Appointments

OMass Therapeutics, a biotechnology company that identifies medicines against highly validated target ecosystems, announces the expansion of its leadership team with the appointment of two senior executives in newly created roles.

August 2, 2023
·
4 min read
InDex Pharmaceuticals has been granted a new patent in Europe for the commercial formulation of cobitolimod

InDex Pharmaceuticals Holding AB announced that a new formulation patent for the drug candidate cobitolimod has been granted by the European Patent Office.

August 2, 2023
·
2 min read
Pharm Country

Molecular Targeting Technologies, Inc. and Molecular Theranostics Center of Singapore Receive HSA Approval for Clinical Trial Authorization for EBTATE® in Nasopharyngeal Cancer

Molecular Targeting Technologies, Inc., and its wholly owned subsidiary, Molecular Theranostic Center of Singapore, announced the approval of a Clinical Trial Authorization application by the Health Sciences Authority of Singapore.

August 2, 2023
·
2 min read
Business

G1 Therapeutics Provides Second Quarter 2023 Financial Results and Operational Highlights

G1 Therapeutics, Inc., a commercial-stage oncology company, provided a corporate and financial update for the second quarter ended June 30, 2023.

August 2, 2023
·
14 min read